Brightworth’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-28,625
Closed -$87K – 89
2019
Q1
$87K Hold
28,625
– – 0.02% 92
2018
Q4
$45K Hold
28,625
– – 0.01% 90
2018
Q3
$78K Hold
28,625
– – 0.02% 92
2018
Q2
$75K Hold
28,625
– – 0.02% 90
2018
Q1
$79K Buy
+28,625
New +$80.9K 0.02% 125

Other funds holding AVXL

Brightworth's AVXL Position: Q2 2019 in Review

Brightworth sold out of Anavex Life Sciences (AVXL) in Q2 2019, closing a stake of 28,625 shares — an estimated $87K sold.

Brightworth first reported a position in AVXL in Q1 2018 and held it in 5 quarters. The position peaked at $87K in Q1 2019. 59 funds tracked by Wall St. Rank hold AVXL as of Q2 2019.

  • Brightworth reported no remaining Anavex Life Sciences position as of Q2 2019 after selling out during the quarter.
  • Brightworth sold 28,625 Anavex Life Sciences shares in Q2 2019, an estimated $87K.
  • Brightworth first reported a position in Anavex Life Sciences in Q1 2018 and held it in 5 quarters.
  • Brightworth's Anavex Life Sciences position peaked at $87K in Q1 2019.
  • 59 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2019.

Based on Brightworth's 13F filing for Q2 2019, filed 31 Jul 2019.